Skip to content

Efficacy of VR-CET combined with RTMS in the treatment of alcohol addiction

Efficacy of VR-CET combined with RTMS in the treatment of alcohol addiction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076184
Enrollment
Unknown
Registered
2023-09-21
Start date
2023-09-28
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Addiction/dependence

Interventions

VR-rTMS treatment group:Virtual reality-cue exposure therapy combined with repetitive transcranial magnetic stimulation
rTMS treatment group:repetitive transcranial magnetic stimulation
Virtual reality-cue exposure therapy group:Virtual reality-cue exposure therapy
Drug Treatment Group:Conventional drug treatment

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 18-60 years old, Chinese male, right-handed;The clinical diagnostic criteria for alcohol use disorders in DSM-5 were met;The score of CIWA-Ar was < 7;The visual analogy scale showed psychological craving

Exclusion criteria

Exclusion criteria: There are serious heart, liver, kidney and other physical diseases;People with active tuberculosis, HIV or syphilis infectious disease;Those with other severe mental illness or obvious psychotic symptoms;Incorporate other substance abusers;There are any contraindications to rTMS, such as intracranial intraocular metal implants, artificial pacemaker, metal heart valves or stents.;Previous seizures, brain trauma, cerebral hemorrhage and other organic disease history

Design outcomes

Primary

MeasureTime frame
Re-drinking rate within 6 months after treatment;

Secondary

MeasureTime frame
Visual analog scale score;Barratt impulse scale score;Compulsive drinking questionnaire scores;

Countries

China

Contacts

Public ContactLan Xiaochang

The Affiliated Brain Hospital of Guangzhou Medical University

missy_lan@126.com+86 135 7097 9619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026